Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

MDS State of the Art: Imetelstat/Roxadustat for Anemia, Oral HMAs, Aza Combinations, APR-246 in TP53 Mutations, Magrolimab+Aza in MDS/AML, Enasidenib for HR IDH2 Mutations, Ven+Aza as 1L

131 views
February 3, 2021
Comments 0
Login to view comments. Click here to Login